2017 US Respiratory Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

March 2017 | 283 pages | ID: UC73B29ABECEN
Venture Planning Group

Abstracts

About This Report

This new 283-page report from VPGMarketResearch.com presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs.

In addition to market share and sales forecasts, the report:

• Examines market applications of Molecular Diagnostics,Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
• Reviews features and operating characteristics of major analyzers usedfor microbiology testing;
• Profiles key suppliers and potential market entrants developing innovativetechnologies and products; and
• Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchs proprietary data files was conducted.

Contains 283 pages and 23 tables

Contents

INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major 1nfectious Disease Tests
  1. ADENO6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
    d. Adeno-Associated 5iruses(AA5)
  2. 1NFLUENZA 6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  3. LEG1ONELLA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  4. MONONUCLEOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  5. MYCOPLASMA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  6. PNEUMON1A
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  7. RESP1RATORY SYNCYT1AL 6RUS (RS5)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  8. TUBERCULOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
B. 1nstrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. MOLECULAR D1AGNOST1CS
  2. MONOCLONAL ANT1BOD1ES
  3. 1MMUNOASSAYS
  4. D1FFERENT1AL L1GHT SCATTER1NG
  5. 1NFORMAT1ON TECHNOLOGY
  6. ART1F1C1AL 1NTELL1GENCE
  7. L1POSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. D1AGNOST1C 1MAG1NG
  11. GEL M1CRODROPLETS
  12. OTHER

IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

Major Product Development Opportunities
A. 1nstrumentation
B. Reagent Kits and Test Systems/panels
C. 1nformation Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKET1NG APPROACHES
  2. PRODUCT COMPLE11TY
  3. CUSTOMER PREFERENCE
  4. ESTABL1SHED SUPPL1ERS
  5. EMERG1NG SUPPL1ERS
  6. MAJOR TYPES OF D1STR1BUTORS
  7. MARKET SEGMENTAT1ON

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
1D Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

L1ST OF TABLES

Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing 1nfluenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RS5 Tests
Major Companies Developing or Marketing Tuberculosis Tests
U.S.A. Adenovirus Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. 1nfluenza Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S.A. 1nfluenza Testing Market Diagnostics Sales by Major Supplier
U.S.A. Legionella Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mononucleosis Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Pneumonia Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.S.A. RS5 Test 5olume and Diagnostics Sales Forecast by Market Segment
U.S.A. RS5 Testing Market Diagnostics Sales by Major Supplier
U.S.A. Tuberculosis Test 5olume and Diagnostics Sales Forecast by Market Segment